Visa Other Non-Current Liabilities increased by 16.6% to $2.00B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.9%, from $2.47B to $2.00B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -17.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.62B | $3.46B | $3.42B | $3.56B | $3.39B | $3.54B | $3.18B | $3.03B | $3.08B | $3.09B | $3.06B | $2.72B | $2.98B | $2.72B | $2.63B | $2.47B | $1.59B | $1.52B | $1.72B | $2.00B |
| QoQ Change | — | -4.4% | -1.3% | +4.1% | -4.8% | +4.4% | -10.0% | -4.9% | +1.9% | +0.3% | -0.9% | -11.1% | +9.4% | -8.7% | -3.3% | -6.1% | -35.7% | -4.3% | +13.0% | +16.6% |
| YoY Change | — | — | — | — | -6.5% | +2.1% | -6.9% | -15.0% | -9.0% | -12.6% | -3.6% | -10.0% | -3.4% | -12.0% | -14.2% | -9.4% | -46.7% | -44.2% | -34.7% | -18.9% |